CA2439111A1

CA2439111A1 - Mucosal boosting following parenteral priming

Mucosal boosting following parenteral priming Download PDF

Info

Publication number: CA2439111A1
Authority: CA; Canada
Prior art keywords: antigens; virus; immunogenic composition; immune response; antigen
Prior art date: 2001-04-05
Legal status : Abandoned

Application number

CA002439111A

Other languages

English (en)

French (fr)

Inventor

Derek O'hagan

Current Assignee

Novartis Vaccines and Diagnostics Inc

Original Assignee

Individual

Priority date

2001-04-05

Filing date

2002-04-05

Publication date

2002-10-17

2002-04-05 Application filed by Individual filed Critical Individual

2002-10-17 Publication of CA2439111A1 publication Critical patent/CA2439111A1/en

Status Abandoned legal-status Critical Current

Links

230000037452 priming Effects 0.000 title description 21
239000000427 antigen Substances 0.000 claims abstract description 189
108091007433 antigens Proteins 0.000 claims abstract description 189
102000036639 antigens Human genes 0.000 claims abstract description 189
238000007911 parenteral administration Methods 0.000 claims abstract description 11
238000000034 method Methods 0.000 claims description 107
239000000203 mixture Substances 0.000 claims description 104
230000002163 immunogen Effects 0.000 claims description 62
239000011859 microparticle Substances 0.000 claims description 56
108090000765 processed proteins & peptides Proteins 0.000 claims description 53
102000004196 processed proteins & peptides Human genes 0.000 claims description 50
241000700605 Viruses Species 0.000 claims description 41
230000028993 immune response Effects 0.000 claims description 41
229920001184 polypeptide Polymers 0.000 claims description 38
241000725303 Human immunodeficiency virus Species 0.000 claims description 36
206010028980 Neoplasm Diseases 0.000 claims description 31
244000052769 pathogen Species 0.000 claims description 30
102000040430 polynucleotide Human genes 0.000 claims description 30
108091033319 polynucleotide Proteins 0.000 claims description 30
239000002157 polynucleotide Substances 0.000 claims description 30
241000894006 Bacteria Species 0.000 claims description 18
230000001717 pathogenic effect Effects 0.000 claims description 15
150000001720 carbohydrates Chemical class 0.000 claims description 14
241000711549 Hepacivirus C Species 0.000 claims description 11
241000588650 Neisseria meningitidis Species 0.000 claims description 11
241000700584 Simplexvirus Species 0.000 claims description 9
241000700721 Hepatitis B virus Species 0.000 claims description 8
241000713772 Human immunodeficiency virus 1 Species 0.000 claims description 8
241000725643 Respiratory syncytial virus Species 0.000 claims description 8
241000606768 Haemophilus influenzae Species 0.000 claims description 7
241000701806 Human papillomavirus Species 0.000 claims description 7
230000009885 systemic effect Effects 0.000 claims description 7
241000709721 Hepatovirus A Species 0.000 claims description 6
229920001542 oligosaccharide Polymers 0.000 claims description 6
150000002482 oligosaccharides Chemical class 0.000 claims description 6
206010022000 influenza Diseases 0.000 claims description 5
241000193998 Streptococcus pneumoniae Species 0.000 claims description 4
230000001939 inductive effect Effects 0.000 claims description 4
229940031000 streptococcus pneumoniae Drugs 0.000 claims description 4
208000002606 Paramyxoviridae Infections Diseases 0.000 claims description 3
241000193985 Streptococcus agalactiae Species 0.000 claims description 3
230000016379 mucosal immune response Effects 0.000 claims description 3
108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 claims description 2
229940045808 haemophilus influenzae type b Drugs 0.000 claims 2
230000003053 immunization Effects 0.000 abstract description 22
238000002649 immunization Methods 0.000 abstract description 22
108090000623 proteins and genes Proteins 0.000 description 79
102000004169 proteins and genes Human genes 0.000 description 62
229960005486 vaccine Drugs 0.000 description 47
210000004027 cell Anatomy 0.000 description 33
238000007918 intramuscular administration Methods 0.000 description 24
229920000642 polymer Polymers 0.000 description 23
239000002671 adjuvant Substances 0.000 description 21
108020004414 DNA Proteins 0.000 description 19
239000002245 particle Substances 0.000 description 19
210000002966 serum Anatomy 0.000 description 19
239000002502 liposome Substances 0.000 description 18
239000013598 vector Substances 0.000 description 18
229920002521 macromolecule Polymers 0.000 description 17
108091032973 (ribonucleotides)n+m Proteins 0.000 description 16
102000039446 nucleic acids Human genes 0.000 description 16
108020004707 nucleic acids Proteins 0.000 description 16
150000007523 nucleic acids Chemical class 0.000 description 16
-1 poly(alpha-hydroxy acid) Polymers 0.000 description 15
238000001476 gene delivery Methods 0.000 description 14
238000004519 manufacturing process Methods 0.000 description 14
239000000463 material Substances 0.000 description 14
230000004044 response Effects 0.000 description 14
210000001744 T-lymphocyte Anatomy 0.000 description 13
102000004127 Cytokines Human genes 0.000 description 12
108090000695 Cytokines Proteins 0.000 description 12
241001465754 Metazoa Species 0.000 description 12
238000003556 assay Methods 0.000 description 12
150000001413 amino acids Chemical class 0.000 description 11
230000004048 modification Effects 0.000 description 11
238000012986 modification Methods 0.000 description 11
239000003981 vehicle Substances 0.000 description 11
241000699670 Mus sp. Species 0.000 description 10
230000001580 bacterial effect Effects 0.000 description 10
239000000969 carrier Substances 0.000 description 10
230000014509 gene expression Effects 0.000 description 10
238000002360 preparation method Methods 0.000 description 10
230000003612 virological effect Effects 0.000 description 10
101800001690 Transmembrane protein gp41 Proteins 0.000 description 9
239000002253 acid Substances 0.000 description 9
229920001577 copolymer Polymers 0.000 description 9
150000002632 lipids Chemical class 0.000 description 9
RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 8
101100341029 Caenorhabditis elegans inx-3 gene Proteins 0.000 description 8
102100034349 Integrase Human genes 0.000 description 8
206010046865 Vaccinia virus infection Diseases 0.000 description 8
125000002091 cationic group Chemical group 0.000 description 8
230000000694 effects Effects 0.000 description 8
239000000839 emulsion Substances 0.000 description 8
238000009472 formulation Methods 0.000 description 8
150000004676 glycans Chemical class 0.000 description 8
239000007924 injection Substances 0.000 description 8
238000002347 injection Methods 0.000 description 8
229920001282 polysaccharide Polymers 0.000 description 8
239000005017 polysaccharide Substances 0.000 description 8
208000007089 vaccinia Diseases 0.000 description 8
208000030507 AIDS Diseases 0.000 description 7
241000271566 Aves Species 0.000 description 7
241000124008 Mammalia Species 0.000 description 7
241000700618 Vaccinia virus Species 0.000 description 7
229940037003 alum Drugs 0.000 description 7
230000000890 antigenic effect Effects 0.000 description 7
238000003776 cleavage reaction Methods 0.000 description 7
239000003599 detergent Substances 0.000 description 7
230000004927 fusion Effects 0.000 description 7
238000001415 gene therapy Methods 0.000 description 7
230000036039 immunity Effects 0.000 description 7
230000007017 scission Effects 0.000 description 7
239000000243 solution Substances 0.000 description 7
238000011282 treatment Methods 0.000 description 7
108010049048 Cholera Toxin Proteins 0.000 description 6
102000009016 Cholera Toxin Human genes 0.000 description 6
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
101710177291 Gag polyprotein Proteins 0.000 description 6
125000003275 alpha amino acid group Chemical group 0.000 description 6
230000001413 cellular effect Effects 0.000 description 6
210000002443 helper t lymphocyte Anatomy 0.000 description 6
208000015181 infectious disease Diseases 0.000 description 6
JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 6
230000001404 mediated effect Effects 0.000 description 6
239000000126 substance Substances 0.000 description 6
241001430294 unidentified retrovirus Species 0.000 description 6
JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 5
241000701022 Cytomegalovirus Species 0.000 description 5
241000588724 Escherichia coli Species 0.000 description 5
108700018351 Major Histocompatibility Complex Proteins 0.000 description 5
230000024932 T cell mediated immunity Effects 0.000 description 5
201000011510 cancer Diseases 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
239000012634 fragment Substances 0.000 description 5
231100000252 nontoxic Toxicity 0.000 description 5
230000003000 nontoxic effect Effects 0.000 description 5
244000045947 parasite Species 0.000 description 5
229920000747 poly(lactic acid) Polymers 0.000 description 5
239000000047 product Substances 0.000 description 5
230000001681 protective effect Effects 0.000 description 5
238000012552 review Methods 0.000 description 5
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 5
239000000725 suspension Substances 0.000 description 5
230000014616 translation Effects 0.000 description 5
241000701161 unidentified adenovirus Species 0.000 description 5
KWVJHCQQUFDPLU-YEUCEMRASA-N 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KWVJHCQQUFDPLU-YEUCEMRASA-N 0.000 description 4
241000710929 Alphavirus Species 0.000 description 4
241000700663 Avipoxvirus Species 0.000 description 4
102000014914 Carrier Proteins Human genes 0.000 description 4
108010078791 Carrier Proteins Proteins 0.000 description 4
102000019034 Chemokines Human genes 0.000 description 4
108010012236 Chemokines Proteins 0.000 description 4
108091026890 Coding region Proteins 0.000 description 4
238000002965 ELISA Methods 0.000 description 4
241000233866 Fungi Species 0.000 description 4
208000031886 HIV Infections Diseases 0.000 description 4
102000000588 Interleukin-2 Human genes 0.000 description 4
108010002350 Interleukin-2 Proteins 0.000 description 4
201000009906 Meningitis Diseases 0.000 description 4
108091034117 Oligonucleotide Proteins 0.000 description 4
101710116435 Outer membrane protein Proteins 0.000 description 4
241000713311 Simian immunodeficiency virus Species 0.000 description 4
241000251539 Vertebrata <Metazoa> Species 0.000 description 4
238000007792 addition Methods 0.000 description 4
230000003321 amplification Effects 0.000 description 4
125000000129 anionic group Chemical group 0.000 description 4
230000000844 anti-bacterial effect Effects 0.000 description 4
239000000227 bioadhesive Substances 0.000 description 4
238000012217 deletion Methods 0.000 description 4
230000037430 deletion Effects 0.000 description 4
238000011161 development Methods 0.000 description 4
230000018109 developmental process Effects 0.000 description 4
PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
230000002519 immonomodulatory effect Effects 0.000 description 4
210000000987 immune system Anatomy 0.000 description 4
238000001727 in vivo Methods 0.000 description 4
230000003834 intracellular effect Effects 0.000 description 4
238000001990 intravenous administration Methods 0.000 description 4
230000035772 mutation Effects 0.000 description 4
238000003199 nucleic acid amplification method Methods 0.000 description 4
239000008194 pharmaceutical composition Substances 0.000 description 4
238000003752 polymerase chain reaction Methods 0.000 description 4
102000005962 receptors Human genes 0.000 description 4
108020003175 receptors Proteins 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
238000002741 site-directed mutagenesis Methods 0.000 description 4
238000007920 subcutaneous administration Methods 0.000 description 4
238000006467 substitution reaction Methods 0.000 description 4
230000001225 therapeutic effect Effects 0.000 description 4
210000001519 tissue Anatomy 0.000 description 4
238000013519 translation Methods 0.000 description 4
241000712461 unidentified influenza virus Species 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
108010029697 CD40 Ligand Proteins 0.000 description 3
102100032937 CD40 ligand Human genes 0.000 description 3
108010039939 Cell Wall Skeleton Proteins 0.000 description 3
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 3
101710091045 Envelope protein Proteins 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
102000003886 Glycoproteins Human genes 0.000 description 3
108090000288 Glycoproteins Proteins 0.000 description 3
241000282412 Homo Species 0.000 description 3
241000700588 Human alphaherpesvirus 1 Species 0.000 description 3
241000701085 Human alphaherpesvirus 3 Species 0.000 description 3
241000701044 Human gammaherpesvirus 4 Species 0.000 description 3
241000713340 Human immunodeficiency virus 2 Species 0.000 description 3
102000000646 Interleukin-3 Human genes 0.000 description 3
108010002386 Interleukin-3 Proteins 0.000 description 3
102000004889 Interleukin-6 Human genes 0.000 description 3
108090001005 Interleukin-6 Proteins 0.000 description 3
101710125418 Major capsid protein Proteins 0.000 description 3
241000588653 Neisseria Species 0.000 description 3
108091028043 Nucleic acid sequence Proteins 0.000 description 3
229920002732 Polyanhydride Polymers 0.000 description 3
229920001710 Polyorthoester Polymers 0.000 description 3
239000004372 Polyvinyl alcohol Substances 0.000 description 3
101710188315 Protein X Proteins 0.000 description 3
102000014128 RANK Ligand Human genes 0.000 description 3
108010025832 RANK Ligand Proteins 0.000 description 3
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
206010043376 Tetanus Diseases 0.000 description 3
230000004913 activation Effects 0.000 description 3
230000005875 antibody response Effects 0.000 description 3
210000003719 b-lymphocyte Anatomy 0.000 description 3
230000004071 biological effect Effects 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
210000002421 cell wall Anatomy 0.000 description 3
210000004520 cell wall skeleton Anatomy 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
239000011248 coating agent Substances 0.000 description 3
238000000576 coating method Methods 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
238000013270 controlled release Methods 0.000 description 3
231100000433 cytotoxic Toxicity 0.000 description 3
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 3
230000001472 cytotoxic effect Effects 0.000 description 3
201000010099 disease Diseases 0.000 description 3
239000003937 drug carrier Substances 0.000 description 3
230000002708 enhancing effect Effects 0.000 description 3
208000002672 hepatitis B Diseases 0.000 description 3
208000029570 hepatitis D virus infection Diseases 0.000 description 3
230000005847 immunogenicity Effects 0.000 description 3
239000003022 immunostimulating agent Substances 0.000 description 3
229940076264 interleukin-3 Drugs 0.000 description 3
229940100601 interleukin-6 Drugs 0.000 description 3
210000000265 leukocyte Anatomy 0.000 description 3
230000021633 leukocyte mediated immunity Effects 0.000 description 3
239000003446 ligand Substances 0.000 description 3
239000007788 liquid Substances 0.000 description 3
210000004698 lymphocyte Anatomy 0.000 description 3
238000013507 mapping Methods 0.000 description 3
239000012528 membrane Substances 0.000 description 3
238000006384 oligomerization reaction Methods 0.000 description 3
239000003960 organic solvent Substances 0.000 description 3
230000003071 parasitic effect Effects 0.000 description 3
239000000546 pharmaceutical excipient Substances 0.000 description 3
239000013612 plasmid Substances 0.000 description 3
239000002745 poly(ortho ester) Substances 0.000 description 3
229920001610 polycaprolactone Polymers 0.000 description 3
239000004632 polycaprolactone Substances 0.000 description 3
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
229920000053 polysorbate 80 Polymers 0.000 description 3
229920002451 polyvinyl alcohol Polymers 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
230000010076 replication Effects 0.000 description 3
239000003381 stabilizer Substances 0.000 description 3
229940031626 subunit vaccine Drugs 0.000 description 3
239000003053 toxin Substances 0.000 description 3
231100000765 toxin Toxicity 0.000 description 3
108700012359 toxins Proteins 0.000 description 3
238000002255 vaccination Methods 0.000 description 3
210000002845 virion Anatomy 0.000 description 3
YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 2
LDGWQMRUWMSZIU-LQDDAWAPSA-M 2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-LQDDAWAPSA-M 0.000 description 2
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 2
GUQQBLRVXOUDTN-XOHPMCGNSA-N 3-[dimethyl-[3-[[(4r)-4-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 GUQQBLRVXOUDTN-XOHPMCGNSA-N 0.000 description 2
CERZMXAJYMMUDR-QBTAGHCHSA-N 5-amino-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid Chemical compound N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO CERZMXAJYMMUDR-QBTAGHCHSA-N 0.000 description 2
241000272517 Anseriformes Species 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
102100025570 Cancer/testis antigen 1 Human genes 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 2
241000283707 Capra Species 0.000 description 2
102100025064 Cellular tumor antigen p53 Human genes 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
206010008631 Cholera Diseases 0.000 description 2
102000007644 Colony-Stimulating Factors Human genes 0.000 description 2
108010071942 Colony-Stimulating Factors Proteins 0.000 description 2
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
241000725619 Dengue virus Species 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
206010014611 Encephalitis venezuelan equine Diseases 0.000 description 2
241000709661 Enterovirus Species 0.000 description 2
241000283086 Equidae Species 0.000 description 2
241000282326 Felis catus Species 0.000 description 2
241000531123 GB virus C Species 0.000 description 2
108010000227 GP 140 Proteins 0.000 description 2
241000272496 Galliformes Species 0.000 description 2
241000287828 Gallus gallus Species 0.000 description 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
241000590002 Helicobacter pylori Species 0.000 description 2
208000005176 Hepatitis C Diseases 0.000 description 2
241000724675 Hepatitis E virus Species 0.000 description 2
101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 2
241000701074 Human alphaherpesvirus 2 Species 0.000 description 2
102000000589 Interleukin-1 Human genes 0.000 description 2
108010002352 Interleukin-1 Proteins 0.000 description 2
102000003815 Interleukin-11 Human genes 0.000 description 2
108090000177 Interleukin-11 Proteins 0.000 description 2
102000013462 Interleukin-12 Human genes 0.000 description 2
108010065805 Interleukin-12 Proteins 0.000 description 2
102000004125 Interleukin-1alpha Human genes 0.000 description 2
108010082786 Interleukin-1alpha Proteins 0.000 description 2
102000004058 Leukemia inhibitory factor Human genes 0.000 description 2
108090000581 Leukemia inhibitory factor Proteins 0.000 description 2
102000008072 Lymphokines Human genes 0.000 description 2
108010074338 Lymphokines Proteins 0.000 description 2
239000004472 Lysine Substances 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 2
108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
102100022430 Melanocyte protein PMEL Human genes 0.000 description 2
206010027202 Meningitis bacterial Diseases 0.000 description 2
108700020354 N-acetylmuramyl-threonyl-isoglutamine Proteins 0.000 description 2
241000588677 Neisseria meningitidis serogroup B Species 0.000 description 2
102000001068 Neural Cell Adhesion Molecules Human genes 0.000 description 2
108010069196 Neural Cell Adhesion Molecules Proteins 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
241001494479 Pecora Species 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
201000005702 Pertussis Diseases 0.000 description 2
108010081690 Pertussis Toxin Proteins 0.000 description 2
241000286209 Phasianidae Species 0.000 description 2
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
108010039918 Polylysine Proteins 0.000 description 2
241000288906 Primates Species 0.000 description 2
239000004365 Protease Substances 0.000 description 2
101710149951 Protein Tat Proteins 0.000 description 2
241000194017 Streptococcus Species 0.000 description 2
241000282887 Suidae Species 0.000 description 2
101800001271 Surface protein Proteins 0.000 description 2
BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
102000036693 Thrombopoietin Human genes 0.000 description 2
108010041111 Thrombopoietin Proteins 0.000 description 2
102000006601 Thymidine Kinase Human genes 0.000 description 2
108020004440 Thymidine kinase Proteins 0.000 description 2
108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
102000003425 Tyrosinase Human genes 0.000 description 2
108060008724 Tyrosinase Proteins 0.000 description 2
108010046334 Urease Proteins 0.000 description 2
208000002687 Venezuelan Equine Encephalomyelitis Diseases 0.000 description 2
201000009145 Venezuelan equine encephalitis Diseases 0.000 description 2
DSNRWDQKZIEDDB-GCMPNPAFSA-N [(2r)-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(z)-octadec-9-enoyl]oxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C/CCCCCCCC DSNRWDQKZIEDDB-GCMPNPAFSA-N 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 2
230000030741 antigen processing and presentation Effects 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
201000009904 bacterial meningitis Diseases 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
230000007969 cellular immunity Effects 0.000 description 2
235000013330 chicken meat Nutrition 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
230000002939 deleterious effect Effects 0.000 description 2
229960003964 deoxycholic acid Drugs 0.000 description 2
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 2
KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
206010013023 diphtheria Diseases 0.000 description 2
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000008030 elimination Effects 0.000 description 2
238000003379 elimination reaction Methods 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
108010078428 env Gene Products Proteins 0.000 description 2
239000013604 expression vector Substances 0.000 description 2
230000006870 function Effects 0.000 description 2
230000002538 fungal effect Effects 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
229940047650 haemophilus influenzae Drugs 0.000 description 2
229940037467 helicobacter pylori Drugs 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
230000003308 immunostimulating effect Effects 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
208000037797 influenza A Diseases 0.000 description 2
229940074383 interleukin-11 Drugs 0.000 description 2
229940117681 interleukin-12 Drugs 0.000 description 2
238000007912 intraperitoneal administration Methods 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
IZWSFJTYBVKZNK-UHFFFAOYSA-N lauryl sulfobetaine Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-N 0.000 description 2
239000006166 lysate Substances 0.000 description 2
210000002540 macrophage Anatomy 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
238000005259 measurement Methods 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
210000004379 membrane Anatomy 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
JMUHBNWAORSSBD-WKYWBUFDSA-N mifamurtide Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC)COP(O)(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O JMUHBNWAORSSBD-WKYWBUFDSA-N 0.000 description 2
229960005225 mifamurtide Drugs 0.000 description 2
210000004877 mucosa Anatomy 0.000 description 2
125000001446 muramyl group Chemical group N[C@@H](C=O)[C@@H](O[C@@H](C(=O)*)C)[C@H](O)[C@H](O)CO 0.000 description 2
GCRLIVCNZWDCDE-SJXGUFTOSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]nonanamide Chemical compound CCCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO GCRLIVCNZWDCDE-SJXGUFTOSA-N 0.000 description 2
SBWGZAXBCCNRTM-CTHBEMJXSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]octanamide Chemical compound CCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SBWGZAXBCCNRTM-CTHBEMJXSA-N 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
235000021317 phosphate Nutrition 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 2
229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
229920000656 polylysine Polymers 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
230000002685 pulmonary effect Effects 0.000 description 2
230000001177 retroviral effect Effects 0.000 description 2
238000004626 scanning electron microscopy Methods 0.000 description 2
230000028327 secretion Effects 0.000 description 2
239000007787 solid Substances 0.000 description 2
238000000935 solvent evaporation Methods 0.000 description 2
241000894007 species Species 0.000 description 2
ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
238000001694 spray drying Methods 0.000 description 2
229940031439 squalene Drugs 0.000 description 2
TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
239000007858 starting material Substances 0.000 description 2
238000003860 storage Methods 0.000 description 2
229940030998 streptococcus agalactiae Drugs 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
238000012360 testing method Methods 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
238000001890 transfection Methods 0.000 description 2
238000012546 transfer Methods 0.000 description 2
238000011830 transgenic mouse model Methods 0.000 description 2
XETCRXVKJHBPMK-MJSODCSWSA-N trehalose 6,6'-dimycolate Chemical compound C([C@@H]1[C@H]([C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C(CCCCCCCCCCC3C(C3)CCCCCCCCCCCCCCCCCC)C(O)CCCCCCCCCCCCCCCCCCCCCCCCC)O2)O)O1)O)OC(=O)C(C(O)CCCCCCCCCCCCCCCCCCCCCCCCC)CCCCCCCCCCC1CC1CCCCCCCCCCCCCCCCCC XETCRXVKJHBPMK-MJSODCSWSA-N 0.000 description 2
102000003390 tumor necrosis factor Human genes 0.000 description 2
241001529453 unidentified herpesvirus Species 0.000 description 2
239000002691 unilamellar liposome Substances 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 2
BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
YHQZWWDVLJPRIF-JLHRHDQISA-N (4R)-4-[[(2S,3R)-2-[acetyl-[(3R,4R,5S,6R)-3-amino-4-[(1R)-1-carboxyethoxy]-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-3-hydroxybutanoyl]amino]-5-amino-5-oxopentanoic acid Chemical compound C(C)(=O)N([C@@H]([C@H](O)C)C(=O)N[C@H](CCC(=O)O)C(N)=O)C1[C@H](N)[C@@H](O[C@@H](C(=O)O)C)[C@H](O)[C@H](O1)CO YHQZWWDVLJPRIF-JLHRHDQISA-N 0.000 description 1
TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 1
VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
NKOTXYPTXKUCDL-UHFFFAOYSA-N 4-(trifluoromethyl)pyrimidin-2-amine Chemical compound NC1=NC=CC(C(F)(F)F)=N1 NKOTXYPTXKUCDL-UHFFFAOYSA-N 0.000 description 1
102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 1
WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
239000013607 AAV vector Substances 0.000 description 1
108700001666 APC Genes Proteins 0.000 description 1
241000714195 Aids-associated retrovirus Species 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
239000005995 Aluminium silicate Substances 0.000 description 1
241000712892 Arenaviridae Species 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
102100035526 B melanoma antigen 1 Human genes 0.000 description 1
WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 1
231100000699 Bacterial toxin Toxicity 0.000 description 1
108060000903 Beta-catenin Proteins 0.000 description 1
102000015735 Beta-catenin Human genes 0.000 description 1
241001118702 Border disease virus Species 0.000 description 1
241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 1
102000001902 CC Chemokines Human genes 0.000 description 1
108010040471 CC Chemokines Proteins 0.000 description 1
210000004366 CD4-positive T-lymphocyte Anatomy 0.000 description 1
101100005789 Caenorhabditis elegans cdk-4 gene Proteins 0.000 description 1
101100438971 Caenorhabditis elegans mat-1 gene Proteins 0.000 description 1
241000714198 Caliciviridae Species 0.000 description 1
241000178270 Canarypox virus Species 0.000 description 1
101710132601 Capsid protein Proteins 0.000 description 1
108010022366 Carcinoembryonic Antigen Proteins 0.000 description 1
102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 1
102100026548 Caspase-8 Human genes 0.000 description 1
108090000538 Caspase-8 Proteins 0.000 description 1
241000700198 Cavia Species 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
CXRFDZFCGOPDTD-UHFFFAOYSA-M Cetrimide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)C CXRFDZFCGOPDTD-UHFFFAOYSA-M 0.000 description 1
102000001327 Chemokine CCL5 Human genes 0.000 description 1
108010055166 Chemokine CCL5 Proteins 0.000 description 1
241000606161 Chlamydia Species 0.000 description 1
241001647372 Chlamydia pneumoniae Species 0.000 description 1
241000606153 Chlamydia trachomatis Species 0.000 description 1
239000004380 Cholic acid Substances 0.000 description 1
241000251556 Chordata Species 0.000 description 1
241000193163 Clostridioides difficile Species 0.000 description 1
241000193449 Clostridium tetani Species 0.000 description 1
108010060123 Conjugate Vaccines Proteins 0.000 description 1
241000711573 Coronaviridae Species 0.000 description 1
108700025699 DCC Genes Proteins 0.000 description 1
241000450599 DNA viruses Species 0.000 description 1
206010011878 Deafness Diseases 0.000 description 1
102100037840 Dehydrogenase/reductase SDR family member 2, mitochondrial Human genes 0.000 description 1
208000034423 Delivery Diseases 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
102000001301 EGF receptor Human genes 0.000 description 1
108060006698 EGF receptor Proteins 0.000 description 1
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 1
241000701832 Enterobacteria phage T3 Species 0.000 description 1
241000991587 Enterovirus C Species 0.000 description 1
101710121417 Envelope glycoprotein Proteins 0.000 description 1
241000617590 Escherichia coli K1 Species 0.000 description 1
241000722985 Fidia Species 0.000 description 1
241000711950 Filoviridae Species 0.000 description 1
241000710781 Flaviviridae Species 0.000 description 1
241000710831 Flavivirus Species 0.000 description 1
208000000666 Fowlpox Diseases 0.000 description 1
241000700662 Fowlpox virus Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
102000005720 Glutathione transferase Human genes 0.000 description 1
108010070675 Glutathione transferase Proteins 0.000 description 1
JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
108010007979 Glycocholic Acid Proteins 0.000 description 1
108010035713 Glycodeoxycholic Acid Proteins 0.000 description 1
WVULKSPCQVQLCU-UHFFFAOYSA-N Glycodeoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 WVULKSPCQVQLCU-UHFFFAOYSA-N 0.000 description 1
206010018612 Gonorrhoea Diseases 0.000 description 1
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
208000037357 HIV infectious disease Diseases 0.000 description 1
101150029115 HOPX gene Proteins 0.000 description 1
102000002812 Heat-Shock Proteins Human genes 0.000 description 1
108010004889 Heat-Shock Proteins Proteins 0.000 description 1
241000711557 Hepacivirus Species 0.000 description 1
108700039791 Hepatitis C virus nucleocapsid Proteins 0.000 description 1
208000005331 Hepatitis D Diseases 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
241001272567 Hominoidea Species 0.000 description 1
101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 description 1
101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 1
101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 description 1
241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
241000701027 Human herpesvirus 6 Species 0.000 description 1
241000702617 Human parvovirus B19 Species 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
102000003746 Insulin Receptor Human genes 0.000 description 1
108010001127 Insulin Receptor Proteins 0.000 description 1
108010061833 Integrases Proteins 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
241000710842 Japanese encephalitis virus Species 0.000 description 1
102100020880 Kit ligand Human genes 0.000 description 1
102100031413 L-dopachrome tautomerase Human genes 0.000 description 1
108090001030 Lipoproteins Proteins 0.000 description 1
102000004895 Lipoproteins Human genes 0.000 description 1
208000016604 Lyme disease Diseases 0.000 description 1
208000008771 Lymphadenopathy Diseases 0.000 description 1
108050007007 Lytic murein transglycosylases Proteins 0.000 description 1
108700001646 MCC Genes Proteins 0.000 description 1
102000043131 MHC class II family Human genes 0.000 description 1
108091054438 MHC class II family Proteins 0.000 description 1
108010000410 MSH receptor Proteins 0.000 description 1
241000712079 Measles morbillivirus Species 0.000 description 1
102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 description 1
102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
238000010629 Molecular evolutionary genetics analysis Methods 0.000 description 1
241000588655 Moraxella catarrhalis Species 0.000 description 1
108010008707 Mucin-1 Proteins 0.000 description 1
102100034256 Mucin-1 Human genes 0.000 description 1
108010063954 Mucins Proteins 0.000 description 1
102000015728 Mucins Human genes 0.000 description 1
241000711386 Mumps virus Species 0.000 description 1
241001529936 Murinae Species 0.000 description 1
241000711408 Murine respirovirus Species 0.000 description 1
101100476480 Mus musculus S100a8 gene Proteins 0.000 description 1
125000003047 N-acetyl group Chemical group 0.000 description 1
238000005481 NMR spectroscopy Methods 0.000 description 1
RFDAIACWWDREDC-UHFFFAOYSA-N Na salt-Glycocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 RFDAIACWWDREDC-UHFFFAOYSA-N 0.000 description 1
241000588652 Neisseria gonorrhoeae Species 0.000 description 1
241001174901 Neisseria meningitidis alpha275 Species 0.000 description 1
241000921898 Neisseria meningitidis serogroup A Species 0.000 description 1
241000947238 Neisseria meningitidis serogroup C Species 0.000 description 1
241001573069 Neisseria meningitidis serogroup Y Species 0.000 description 1
108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
108010038807 Oligopeptides Proteins 0.000 description 1
102000015636 Oligopeptides Human genes 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
241000712464 Orthomyxoviridae Species 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
108010058846 Ovalbumin Proteins 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 1
102100034640 PWWP domain-containing DNA repair factor 3A Human genes 0.000 description 1
108050007154 PWWP domain-containing DNA repair factor 3A Proteins 0.000 description 1
241000282579 Pan Species 0.000 description 1
241000711504 Paramyxoviridae Species 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108010043958 Peptoids Proteins 0.000 description 1
241000150350 Peribunyaviridae Species 0.000 description 1
241000710778 Pestivirus Species 0.000 description 1
241000709664 Picornaviridae Species 0.000 description 1
229920001244 Poly(D,L-lactide) Polymers 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
241000605862 Porphyromonas gingivalis Species 0.000 description 1
101710188053 Protein D Proteins 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
101000933967 Pseudomonas phage KPP25 Major capsid protein Proteins 0.000 description 1
206010037660 Pyrexia Diseases 0.000 description 1
241000711798 Rabies lyssavirus Species 0.000 description 1
241000700159 Rattus Species 0.000 description 1
208000035415 Reinfection Diseases 0.000 description 1
241000702247 Reoviridae Species 0.000 description 1
101710132893 Resolvase Proteins 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
241000710799 Rubella virus Species 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
208000019802 Sexually transmitted disease Diseases 0.000 description 1
101710084578 Short neurotoxin 1 Proteins 0.000 description 1
241000710960 Sindbis virus Species 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
108010088160 Staphylococcal Protein A Proteins 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
108010039445 Stem Cell Factor Proteins 0.000 description 1
241000193996 Streptococcus pyogenes Species 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
241000192581 Synechocystis sp. Species 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
208000000389 T-cell leukemia Diseases 0.000 description 1
208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
WBWWGRHZICKQGZ-UHFFFAOYSA-N Taurocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)C(O)C2 WBWWGRHZICKQGZ-UHFFFAOYSA-N 0.000 description 1
108010017842 Telomerase Proteins 0.000 description 1
108010034949 Thyroglobulin Proteins 0.000 description 1
102000009843 Thyroglobulin Human genes 0.000 description 1
241000710771 Tick-borne encephalitis virus Species 0.000 description 1
241000710924 Togaviridae Species 0.000 description 1
101710182223 Toxin B Proteins 0.000 description 1
101710182532 Toxin a Proteins 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
108090000848 Ubiquitin Proteins 0.000 description 1
102000044159 Ubiquitin Human genes 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
241000710886 West Nile virus Species 0.000 description 1
108700025700 Wilms Tumor Genes Proteins 0.000 description 1
241000710772 Yellow fever virus Species 0.000 description 1
KGUHOFWIXKIURA-VQXBOQCVSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl dodecanoate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCC)O[C@@H]1O[C@@]1(CO)[C@@H](O)[C@H](O)[C@@H](CO)O1 KGUHOFWIXKIURA-VQXBOQCVSA-N 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 1
150000001242 acetic acid derivatives Chemical class 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
238000005903 acid hydrolysis reaction Methods 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
238000012382 advanced drug delivery Methods 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000037006 agalactosis Effects 0.000 description 1
238000013019 agitation Methods 0.000 description 1
102000013529 alpha-Fetoproteins Human genes 0.000 description 1
108010026331 alpha-Fetoproteins Proteins 0.000 description 1
230000004075 alteration Effects 0.000 description 1
AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
235000012211 aluminium silicate Nutrition 0.000 description 1
DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
238000010171 animal model Methods 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000003302 anti-idiotype Effects 0.000 description 1
210000000612 antigen-presenting cell Anatomy 0.000 description 1
230000027645 antigenic variation Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000012062 aqueous buffer Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
201000005008 bacterial sepsis Diseases 0.000 description 1
239000000688 bacterial toxin Substances 0.000 description 1
239000000440 bentonite Substances 0.000 description 1
229910000278 bentonite Inorganic materials 0.000 description 1
SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
150000001558 benzoic acid derivatives Chemical class 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
229920002988 biodegradable polymer Polymers 0.000 description 1
239000004621 biodegradable polymer Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000005013 brain tissue Anatomy 0.000 description 1
229950004398 broxuridine Drugs 0.000 description 1
239000000872 buffer Substances 0.000 description 1
244000309464 bull Species 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
210000000234 capsid Anatomy 0.000 description 1
239000002775 capsule Substances 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
238000001516 cell proliferation assay Methods 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
SXPWTBGAZSPLHA-UHFFFAOYSA-M cetalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SXPWTBGAZSPLHA-UHFFFAOYSA-M 0.000 description 1
229960000228 cetalkonium chloride Drugs 0.000 description 1
229940038705 chlamydia trachomatis Drugs 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
235000019416 cholic acid Nutrition 0.000 description 1
229960002471 cholic acid Drugs 0.000 description 1
238000010367 cloning Methods 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
238000011260 co-administration Methods 0.000 description 1
238000005354 coacervation Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
229940031670 conjugate vaccine Drugs 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
108091036078 conserved sequence Proteins 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000012258 culturing Methods 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
210000004443 dendritic cell Anatomy 0.000 description 1
OJSUWTDDXLCUFR-YVKIRAPASA-N deoxy-bigchap Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@H]([C@@H](CCC(=O)N(CCCNC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)CCCNC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)C)[C@@]2(C)[C@H](O)C1 OJSUWTDDXLCUFR-YVKIRAPASA-N 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
UMGXUWVIJIQANV-UHFFFAOYSA-M didecyl(dimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC UMGXUWVIJIQANV-UHFFFAOYSA-M 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
238000002050 diffraction method Methods 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
239000000539 dimer Substances 0.000 description 1
CSNHNGDROQRZKT-DSVPTQILSA-M dimethyl-[(2,3,4,5,6-pentadeuteriophenyl)methyl]-tetradecylazanium bromide Chemical compound [Br-].C(C1=C(C(=C(C(=C1[2H])[2H])[2H])[2H])[2H])[N+](CCCCCCCCCCCCCC)(C)C CSNHNGDROQRZKT-DSVPTQILSA-M 0.000 description 1
231100000676 disease causative agent Toxicity 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
XJWSAJYUBXQQDR-UHFFFAOYSA-M dodecyltrimethylammonium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)C XJWSAJYUBXQQDR-UHFFFAOYSA-M 0.000 description 1
108010051081 dopachrome isomerase Proteins 0.000 description 1
229940079593 drug Drugs 0.000 description 1
241001493065 dsRNA viruses Species 0.000 description 1
238000002296 dynamic light scattering Methods 0.000 description 1
239000012636 effector Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 1
230000008175 fetal development Effects 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
108700014844 flt3 ligand Proteins 0.000 description 1
229940044627 gamma-interferon Drugs 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000000499 gel Substances 0.000 description 1
238000001879 gelation Methods 0.000 description 1
102000034356 gene-regulatory proteins Human genes 0.000 description 1
108091006104 gene-regulatory proteins Proteins 0.000 description 1
102000054766 genetic haplotypes Human genes 0.000 description 1
229940099347 glycocholic acid Drugs 0.000 description 1
RFDAIACWWDREDC-FRVQLJSFSA-N glycocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 RFDAIACWWDREDC-FRVQLJSFSA-N 0.000 description 1
WVULKSPCQVQLCU-BUXLTGKBSA-N glycodeoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 WVULKSPCQVQLCU-BUXLTGKBSA-N 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
208000001786 gonorrhea Diseases 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
239000003721 gunpowder Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
208000005252 hepatitis A Diseases 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
230000028996 humoral immune response Effects 0.000 description 1
150000003840 hydrochlorides Chemical class 0.000 description 1
239000000413 hydrolysate Substances 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
230000000951 immunodiffusion Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
230000017555 immunoglobulin mediated immune response Effects 0.000 description 1
239000000568 immunological adjuvant Substances 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000001524 infective effect Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000002743 insertional mutagenesis Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000004073 interleukin-2 production Effects 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
238000002356 laser light scattering Methods 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
239000006194 liquid suspension Substances 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
208000018555 lymphatic system disease Diseases 0.000 description 1
HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
239000000391 magnesium silicate Substances 0.000 description 1
229910052919 magnesium silicate Inorganic materials 0.000 description 1
235000019792 magnesium silicate Nutrition 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
201000004792 malaria Diseases 0.000 description 1
150000002690 malonic acid derivatives Chemical class 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000035800 maturation Effects 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
208000037941 meningococcal disease Diseases 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
239000011707 mineral Substances 0.000 description 1
ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 description 1
238000001823 molecular biology technique Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
230000001459 mortal effect Effects 0.000 description 1
239000004570 mortar (masonry) Substances 0.000 description 1
108010002832 murein transglycosylase Proteins 0.000 description 1
JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
UMWKZHPREXJQGR-UHFFFAOYSA-N n-methyl-n-(2,3,4,5,6-pentahydroxyhexyl)decanamide Chemical compound CCCCCCCCCC(=O)N(C)CC(O)C(O)C(O)C(O)CO UMWKZHPREXJQGR-UHFFFAOYSA-N 0.000 description 1
UMWKZHPREXJQGR-XOSAIJSUSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]decanamide Chemical compound CCCCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO UMWKZHPREXJQGR-XOSAIJSUSA-N 0.000 description 1
VHYYJWLKCODCNM-OIMNJJJWSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]heptanamide Chemical compound CCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO VHYYJWLKCODCNM-OIMNJJJWSA-N 0.000 description 1
239000007923 nasal drop Substances 0.000 description 1
229940100662 nasal drops Drugs 0.000 description 1
229940100652 nasal gel Drugs 0.000 description 1
210000002850 nasal mucosa Anatomy 0.000 description 1
229940052404 nasal powder Drugs 0.000 description 1
229940097496 nasal spray Drugs 0.000 description 1
239000007922 nasal spray Substances 0.000 description 1
CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
239000007764 o/w emulsion Substances 0.000 description 1
HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 description 1
210000000196 olfactory nerve Anatomy 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
229940092253 ovalbumin Drugs 0.000 description 1
239000006179 pH buffering agent Substances 0.000 description 1
239000003961 penetration enhancing agent Substances 0.000 description 1
239000012071 phase Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
238000000053 physical method Methods 0.000 description 1
108010089520 pol Gene Products Proteins 0.000 description 1
229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
229920001432 poly(L-lactide) Polymers 0.000 description 1
229940065514 poly(lactide) Drugs 0.000 description 1
108010011110 polyarginine Proteins 0.000 description 1
238000006068 polycondensation reaction Methods 0.000 description 1
108010055896 polyornithine Proteins 0.000 description 1
229920002714 polyornithine Polymers 0.000 description 1
229940031937 polysaccharide vaccine Drugs 0.000 description 1
239000000843 powder Substances 0.000 description 1
229940024231 poxvirus vaccine Drugs 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000001566 pro-viral effect Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
238000000746 purification Methods 0.000 description 1
HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
239000001397 quillaja saponaria molina bark Substances 0.000 description 1
230000006798 recombination Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000005057 refrigeration Methods 0.000 description 1
230000009711 regulatory function Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
201000005404 rubella Diseases 0.000 description 1
229930182490 saponin Natural products 0.000 description 1
150000007949 saponins Chemical class 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
230000005582 sexual transmission Effects 0.000 description 1
244000000033 sexually transmitted pathogen Species 0.000 description 1
239000002002 slurry Substances 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
OABYVIYXWMZFFJ-ZUHYDKSRSA-M sodium glycocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 OABYVIYXWMZFFJ-ZUHYDKSRSA-M 0.000 description 1
VMSNAUAEKXEYGP-YEUHZSMFSA-M sodium glycodeoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 VMSNAUAEKXEYGP-YEUHZSMFSA-M 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 description 1
229940045946 sodium taurodeoxycholate Drugs 0.000 description 1
YXHRQQJFKOHLAP-FVCKGWAHSA-M sodium;2-[[(4r)-4-[(3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 YXHRQQJFKOHLAP-FVCKGWAHSA-M 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
229940063673 spermidine Drugs 0.000 description 1
229940063675 spermine Drugs 0.000 description 1
229940032094 squalane Drugs 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
239000000758 substrate Substances 0.000 description 1
229940032085 sucrose monolaurate Drugs 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
208000006379 syphilis Diseases 0.000 description 1
238000007910 systemic administration Methods 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
WBWWGRHZICKQGZ-GIHLXUJPSA-N taurocholic acid Chemical compound C([C@@H]1C[C@H]2O)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@H](O)C1 WBWWGRHZICKQGZ-GIHLXUJPSA-N 0.000 description 1
AWDRATDZQPNJFN-VAYUFCLWSA-N taurodeoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 AWDRATDZQPNJFN-VAYUFCLWSA-N 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
229960000814 tetanus toxoid Drugs 0.000 description 1
229960002175 thyroglobulin Drugs 0.000 description 1
102000004217 thyroid hormone receptors Human genes 0.000 description 1
108090000721 thyroid hormone receptors Proteins 0.000 description 1
241001147422 tick-borne encephalitis virus group Species 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
230000009261 transgenic effect Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000010474 transient expression Effects 0.000 description 1
230000032258 transport Effects 0.000 description 1
230000005532 trapping Effects 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
239000013638 trimer Substances 0.000 description 1
239000003656 tris buffered saline Substances 0.000 description 1
JOPDZQBPOWAEHC-UHFFFAOYSA-H tristrontium;diphosphate Chemical compound [Sr+2].[Sr+2].[Sr+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O JOPDZQBPOWAEHC-UHFFFAOYSA-H 0.000 description 1
201000008827 tuberculosis Diseases 0.000 description 1
WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
229910052721 tungsten Inorganic materials 0.000 description 1
239000010937 tungsten Substances 0.000 description 1
108010014402 tyrosinase-related protein-1 Proteins 0.000 description 1
230000004222 uncontrolled growth Effects 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
239000012646 vaccine adjuvant Substances 0.000 description 1
229940124931 vaccine adjuvant Drugs 0.000 description 1
230000009677 vaginal delivery Effects 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
244000052613 viral pathogen Species 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
238000012070 whole genome sequencing analysis Methods 0.000 description 1
238000002424 x-ray crystallography Methods 0.000 description 1
229940051021 yellow-fever virus Drugs 0.000 description 1